Screener
Oric Pharmaceuticals, Inc. ORIC Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 290,233 | 288,466 |
| Long-term investments | 137,779 | 110,762 |
| Property and equipment, net | 2,147 | 2,415 |
| Other assets | 6,603 | 7,247 |
| Total assets | $436,762 | $408,890 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,895 | $3,824 |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Oric Pharmaceuticals, Inc. (ORIC) reported deferred tax assets and other non-current assets of $6.6M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets decreased by 21.1% year-over-year, from $8.37M to $6.6M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a 86.8% compound annual growth rate (CAGR), from $319K to $7.25M.
Ask your AI about Oric Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude